Search the webpage

Category: Glaucoma

Optic nerve head remodeling is generally considered the earliest manifestation of the glaucomatous triad, resulting in the subsequent damage to the axons of the optic nerve and ultimately retinal ganglion cells death. Optic nerve head astrocytes (ONHAs) are the primary cell type in the optic nerve head, where they provide both structural and nutrient support to the optic nerve. Activation of ONHAs, also referred to reactive astrocytosis or astrogliosis, represents the underlying physiological mechanism of optic nerve head remodeling.

Targeting reactive astrocytosis (“glioprotection”) has recently gained a strong interest in the development of novel pharmaceutical strategies for glaucoma that can supplement IOP-lowering agents.

Experimentica Ltd. offers a validated and standardized screening method for glioprotective drug candidates using primary adult rat ONHAs.

SUMMARY

Species

Rats (Brown Norway)

In vitro insult

Oxidative stress (tert-butylhydroperoxide, tBHP)

Format

96-well plate, tBHP dose response, 8 replicates per concentration

Read-outs

Cell viability assays (e.g. MTT, lactate dehydrogenase)

Please contact us, if you would like to receive more information: info@experimentica.com

IMAGES

Representative examples from primary rat ONHAs

Validated culture of primary adult ONHAs. We use the validated cultures of primary rat adult ONHAs (Kaja et al., 2015) to screen glioprotective drug candidates. ONHAs express the astrocyte markers S100b, EAAT1 and GFAP.

Cell viability assays. Dose-response curve for tBHP using MTT and LDH assays and effect by the prototypic antioxidant Trolox, serving as positive control. Data are shown as mean ± s.e.m. from five separate plates and were analyzed using ANOVA (P < 0.001). # P < 0.01, $ P < 0.001 based on a Bonferroni post-hoc test compared to the control condition (0 mM tBHP).

SELECTED PUBLICATIONS

REFERENCES

  1. Kaja S et al. Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes. Experimental Eye Research 2015; 138: 159-166.

Leave a Comment

LATEST NEWS

Experimentica Ltd. Sponsors the 2018 SILK-Elsemay Björn Symposium

News
Experimentica Ltd. is pleased to announce its co-sponsorship and participation in this year’s SILK - Elsemay Björn Symposium. This yearly ... Read More

Check out our new publication on the mouse dry-eye disease model

An alpha1 adrenergic agonist shows preclinical efficacy in a preclinical model for dry eye syndrome ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!